The latest gynaecological cancer news
Rare combination of ovarian tumours found in one patient
A new case report was published in Oncoscience’s Volume 12 on March 31, 2025, titled “Cystadenofibroma and contralateral…
Browsing: Gynaecologic Cancers
Engineers develop a way to mass manufacture nanoparticles that deliver cancer drugs directly to tumours
Polymer-coated nanoparticles loaded with therapeutic drugs show significant promise for cancer treatment, including ovarian cancer.…
TRIM4 modulates the ubiquitin-mediated degradation of hnRNPDL and weakens sensitivity to CDK4/6 inhibitor in ovarian cancer
Ovarian cancer, a leading cause of death among gynaecological malignancies, has a poor prognosis and…
Platform-predicted treatments improve outcomes for platinum-resistant ovarian cancer
Results from a new Phase 3 trial published in the journal npj Precision Oncology found that a…
Team discovers novel global cooperative phenomena of cell interactions in cervical cancer cells
A Japanese research team has discovered a novel global cooperative phenomenon of cell interactions in…
Uniquely shaped, fast-heating nanoparticles halt ovarian tumour growth
New magnetic nanoparticles in the shape of a cube sandwiched between two pyramids represent a…
New antibody reduces tumour growth in treatment-resistant breast and ovarian cancers
Antibody treatment which activates the patient’s immune system against cancer, known as immunotherapy, is increasingly…
Unveiling the role of tumour-infiltrating immune cells in endometrial carcinoma
A new review article published in Genes & Diseases sheds light on the complex molecular mechanisms through…
Ovarian cancer discovery could turn failed treatment into lifesaver
University of Virginia Cancer Centre researchers (USA) have explained the failure of immune checkpoint therapy…
NICE recommends rucaparib as a first-line maintenance treatment for BRCA-negative advanced ovarian cancer
Pharma and GmbH announced today that the UK’s National Institute of Health and Care Excellence…